Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_assertion type Assertion NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_head.
- NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_assertion description "[Irinotecan should be used cautiously in dialysis patients with metastatic colorectal cancer and screening for UGT1A polymorphisms may help in identifying patients with lower SN-38 glucuronidation rates and greater susceptibility to irinotecan-induced toxicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_provenance.
- NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_assertion evidence source_evidence_literature NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_provenance.
- NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_assertion SIO_000772 21617725 NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_provenance.
- NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_assertion wasDerivedFrom befree-20140225 NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_provenance.
- NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_assertion wasGeneratedBy ECO_0000203 NP350544.RA-lTXMyeOv4CqcntKmg0jetFVwkA_hIhbpy_X4yDEeKA130_provenance.